Redeye
Fredrik Thor is an Equity Research Analyst specializing in life sciences at Redeye AB since August 2020, with a focus on biotech in clinical research, particularly concerning CNS diseases and orphan drugs. Prior experience includes a thesis internship at Regeringskansliet where Fredrik analyzed the impact of competition on grade inflation in the Swedish compulsory school system, and a Business Development Analyst role at Samtrygg AB, a subleasing startup. Fredrik has also held positions as a Teaching Assistant at Uppsala University, a board member of the Department of Economics, and an intern at the Department for International Development Cooperation. Additionally, Fredrik has experience as a writer for the Economics Student Society of Australia and as a freelance journalist for Tidningen Ergo. Fredrik holds a Master of Science in Economics from Uppsala University and completed an exchange year at Monash University, focusing on Politics, Philosophy, and Economics.